Clinical trial
Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial)
NCT00015548 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial)
- Lead sponsor
- National Institute of Mental Health (NIMH)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2001
- Completion date
- October 31, 2004
- Enrollment
- 450
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease